Myking AO - Search Results

1

Prognostic importance of various clinicopathological features in papillary thyroid carcinoma.

Akslen LA, Myking AO, Salvesen H, Varhaug JE. Akslen LA, et al. Among authors: myking ao. Eur J Cancer. 1992;29A(1):44-51. doi: 10.1016/0959-8049(93)90574-y. Eur J Cancer. 1992. PMID: 1445745

2

Differentiated thyroid carcinomas: the relevance of various pathological features for tumour classification and prediction of tumour progress.

Akslen LA, Myking AO. Akslen LA, et al. Among authors: myking ao. Virchows Arch A Pathol Anat Histopathol. 1992;421(1):17-23. doi: 10.1007/BF01607134. Virchows Arch A Pathol Anat Histopathol. 1992. PMID: 1636246

3

Prognostic impact of EGF-receptor in papillary thyroid carcinoma.

Akslen LA, Myking AO, Salvesen H, Varhaug JE. Akslen LA, et al. Among authors: myking ao. Br J Cancer. 1993 Oct;68(4):808-12. doi: 10.1038/bjc.1993.432. Br J Cancer. 1993. PMID: 8398712 Free PMC article.

4

Increased content of chromium and nickel in lung tissues from patients with bronchial carcinoma.

Akslen LA, Myking AO, Mørkve O, Gulsvik A, Raithel HJ, Schaller KH. Akslen LA, et al. Among authors: myking ao. Pathol Res Pract. 1990 Dec;186(6):717-22. doi: 10.1016/S0344-0338(11)80261-X. Pathol Res Pract. 1990. PMID: 2084637

5

Balloon cell melanoma mimicking clear cell carcinoma.

Akslen LA, Myking AO. Akslen LA, et al. Among authors: myking ao. Pathol Res Pract. 1989 May;184(5):548-50; discussion 551-3. doi: 10.1016/S0344-0338(89)80150-5. Pathol Res Pract. 1989. PMID: 2748467

6

Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study.

Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA. Romi F, et al. Eur J Neurol. 2003 Nov;10(6):701-6. doi: 10.1046/j.1468-1331.2003.00678.x. Eur J Neurol. 2003. PMID: 14641516

7

Serum vitamin D metabolites and calcitriol receptor concentration in parathyroid tissue in primary hyperparathyroidism.

Trydal T, Varhaug JE, Myking A, Aksnes L, Aakvaag A, Aarskog D. Trydal T, et al. Acta Endocrinol (Copenh). 1992 Nov;127(5):407-12. doi: 10.1530/acta.0.1270407. Acta Endocrinol (Copenh). 1992. PMID: 1335200

8

Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis.

Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA. Romi F, et al. Eur J Neurol. 2002 Jan;9(1):55-61. doi: 10.1046/j.1468-1331.2002.00352.x. Eur J Neurol. 2002. PMID: 11784377 Clinical Trial.

9

Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies.

Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA. Romi F, et al. Eur Neurol. 2003;49(4):210-7. doi: 10.1159/000070185. Eur Neurol. 2003. PMID: 12736536

10

[Malignant melanoma. Unknown primary tumor and long survival--2 rare case reports].

Akslen LA, Myking AO. Akslen LA, et al. Among authors: myking ao. Tidsskr Nor Laegeforen. 1987 Aug 30;107(24):2047, 2039. Tidsskr Nor Laegeforen. 1987. PMID: 3660390 Norwegian. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters